Ticker Details
Humacyte, Inc. Common Stock
IPO Date:	November 30, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$134.77M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.17 | 3.92%
Avg Daily Range (30 D):	$0.05 | 5.14%
Avg Daily Range (90 D):	$0.05 | 4.49%

Institutional Daily Volume
Avg Daily Volume:	1.98M
Avg Daily Volume (30 D):	7.24M
Avg Daily Volume (90 D):	5.7M

Trade Size
Avg Trade Size (Sh.):	215
Avg Trade Size (Sh.) (30 D):	542
Avg Trade Size (Sh.) (90 D):	444

Institutional Trades
Total Institutional Trades:	304
Avg Institutional Trade:	$1.47M
Avg Institutional Trade (30 D):	$.93M
Avg Institutional Trade (90 D):	$1.65M
Avg Institutional Trade Volume:	.34M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.58M
Avg Closing Trade (30 D):	$.93M
Avg Closing Trade (90 D):	$1.65M
Avg Closing Volume:	346.69K

News

Mar 27, 2026 @ 11:00 AM Humacyte Announces Fourth Quarter and Year End 202... Source: Na

Dec 22, 2025 @ 1:00 PM Humacyte Announces Publication of Long-Term Safety... Source: Na

Nov 12, 2025 @ 4:00 PM Strong Earnings and Biotech Resilience Define the ... Source: Na

Sep 18, 2025 @ 7:08 PM Russell 2000 Hits All-Time Highs: 8 Stocks Power S... Source: Piero Cingari

Aug 11, 2025 @ 11:20 AM Humacyte Posts Q2 Revenue Miss Source: Jesterai

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.26	$-.15	$-.26
Diluted EPS	$-.26	$-.15	$-.26
Revenue	$2.04M	$.47M	$2.04M
Gross Profit	$-7.66M	$-8.62M	$-7.66M
Net Income / Loss	$-40.83M	$-24.8M	$-40.83M
Operating Income / Loss	$-108.14M	$-30.84M	$-108.14M
Cost of Revenue	$9.7M	$9.08M	$9.7M
Net Cash Flow	$-44.44M	$31.01M	$-44.44M
PE Ratio